Limfa Technologies srl® is a young and very innovative company in the biotechnology sector.

The purpose of Limfa Technologies® is to produce cutting-edge products in the electro-medical sector that are a real step forward in the panorama of current offers.

To achieve this result, the company submits its products to rigorous clinical tests of efficacy and safety, beyond that prescribed by ministerial standards.

For this reason it has started, before the actual commercialization, clinical research in the orthopedic and sports field of its flagship product: a device based on magnetic fields of very low intensity with wave modulations able to produce cellular repairs.

The principle on which it is based is that of intra and intercellular communication for which it does not need high powers but only communication strategies: hence a very effective product but completely free of side effects.

The system based on ultra-low magnetic fields (Low Intensity Magnetic Fields) is an electromedical device that generates very low magnetoelectric signals, not comparable traditional physical therapy systems.

The magnetic fields generated by the instrument are analogous to the endogenous electromagnetic forces generated by cellular activity. For this reason the inventors of the instrument have hypothesized that the magneto-electric fields generated by the instrument interact with the cellular magnetic fields (cyclotronon iono-resonance, Liboff 1995) and induce changes on the intra and extra cellular permeability parameters and activate the cellular processes against the states of in fl ammation and edema.

The effectiveness of the system is based on the transmission of information from the device to the injured tissues, through a combined sequence of magnetic fields to the lesionate and suffering cells.

Cervical arthrosis, rotator cuff lesion, lumbosciatalgia, bursitis, epicondylitis, carpal tunnel, post-surgical outcomes, bone fractures and many other things are treated in this way.

Recent studies have shown that more than 80% of patients treated with LIMFA solved the problems with extreme satisfaction and with a number of sessions ranging from 4 to 12.